Delcath Systems to Participate in Upcoming Investor Conferences

NEW YORK, March 8, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that Company management will be attending the following upcoming investor conferences: Leerink Partners Global Biopharma Conference Date: March 13, 2024Location: Miami Beach, FL 36th Annual ROTH ConferenceDate: March 18 - 19, 2024Location: Dana Point, CA Management is scheduled to host one-on-one meetings thr ...